We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Ibrutinib-associated rash: a single-centre experience of clinicopathological features and management.
- Authors
Iberri, David J.; Kwong, Bernice Y.; Stevens, Laurel A.; Coutre, Steven E.; Kim, Jinah; Sabile, Jean M.; Advani, Ranjana H.
- Abstract
The article discusses a study which investigated 14 patients who developed rash while taking ibrutinib for a haematological malignancy at the Stanford Cancer Center. It describes distinct rash subtypes that were observed, including a non-palpable, largely asymptomatic petechial rash. Information is also presented on management of the palpable rash, including the use of topical corticosteroids and oral antihistamines.
- Subjects
DRUG side effects; ANTINEOPLASTIC agents; HORMONE therapy; ADRENOCORTICAL hormones; ANTIHISTAMINES; HEMATOLOGIC malignancies; THERAPEUTICS
- Publication
British Journal of Haematology, 2018, Vol 180, Issue 1, p164
- ISSN
0007-1048
- Publication type
Article
- DOI
10.1111/bjh.14302